Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How do we mention S&L Warrant conversion issue in the letter?

"If Pohl were to say S&L are dumping shares and they won't done until the summer, how many new investors do you think would be attracted to PTSC?"

None? No kidding.

I'm just saying if he actually "knows" S&L is dumping big time, he shouldn't say "anything". Stating that he is "perplexed" indicates that he has "no idea" why the SP declines on good news. No one asked him the question - he came out and made the statement. Given the current scrutiny of today's CEOs, he should know better. If the CEO for the company I work came out and said he's "perplexed" about the company's share price behavior and then we find out that he actually knew exactly why the SP was behaving the way it was, I know for a fact he would be in serious hot water.

Showmanship? I think it could be construed as dishonest and misleading.

Share
New Message
Please login to post a reply